Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

Part of paid clinical trials in Westport, Connecticut.

Sponsor
Galderma R&D
Study ID
NCT07566286
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Chin Augmentation

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Restylane Lyft with Lidocaine — DEVICE
    Sterile gel of hyaluronic acid.

Study Details

The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.

Key Dates

Start date
Jun 1, 2026
Status verified
Apr 2026
Primary completion
Nov 1, 2027
Completion
Feb 28, 2028

Study Design

Enrollment
100 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Dermal Filler for Indication: Restylane Lyft with Lidocaine
    Participants will receive initial treatment with Restylane Lyft with Lidocaine in the chin region at Baseline with an optional touch-up treatment at 1 month after initial treatment and an optional retreatment 12 months after the last treatment.

Primary Outcome Measure

Number of Participants With Treatment-Emergent Adverse Events (TEAEs) Related to Device And/Or Injection Procedure After the Month 12 Optional Retreatment [ Time Frame: From Month 12 up to 3 months after optional retreatment (i.e. Month 15) ]

Central Contacts

Locations (8)

FacilityCityStateZIPSite coordinators
Galderma Investigational Site # 8680WestportConnecticut06880
Galderma Project Manager
Galderma Investigational Site # 8774Boynton BeachFlorida33437
Galderma Project Manager
Galderma Investigational Site # 7030Coral GablesFlorida33134
Galderma Project Manager
Galderma Investigational Site # 8682Coral GablesFlorida33134
Galderma Project Manager
Galderma Investigational Site # 7042AtlantaGeorgia30331
Galderma Project Manager
Galderma Investigational Site # 7043BethesdaMaryland20852
Galderma Project Manager
Galderma Investigational Site # 7118NashvilleTennessee37203-
Galderma Investigational Site # 8662SpringTexas77388
Galderma Project Manager

Find similar trials in Westport, CT